Cyclobenzaprine hydrochloride

Product NDC
76420-840
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Cyclobenzaprine hydrochloride
Dosage form
TABLET, FILM COATED
Route
ORAL
Labeler
Asclemed USA, Inc.
Application
ANDA213324
Marketing category
ANDA
Substance
CYCLOBENZAPRINE HYDROCHLORIDE
Current FDA listing
Yes

Related Records

Packages

Package NDCDescriptionMarketing startMarketing endSampleStatus
76420-840-001000 TABLET, FILM COATED in 1 BOTTLE (76420-840-00) 2024-08-16NoHistorical
76420-840-011 TABLET, FILM COATED in 1 BOTTLE (76420-840-01) 2024-08-16NoHistorical
76420-840-022 TABLET, FILM COATED in 1 BOTTLE (76420-840-02) 2024-08-16NoHistorical
76420-840-077 TABLET, FILM COATED in 1 BOTTLE (76420-840-07) 2024-08-16NoHistorical
76420-840-10100 TABLET, FILM COATED in 1 BOTTLE (76420-840-10) 2024-08-16NoHistorical
76420-840-2020 TABLET, FILM COATED in 1 BOTTLE (76420-840-20) 2024-08-16NoHistorical
76420-840-3030 TABLET, FILM COATED in 1 BOTTLE (76420-840-30) 2024-08-16NoHistorical
76420-840-6060 TABLET, FILM COATED in 1 BOTTLE (76420-840-60) 2024-08-16NoHistorical
76420-840-9090 TABLET, FILM COATED in 1 BOTTLE (76420-840-90) 2024-08-16NoHistorical

Related DailyMed Labels

TitleManufacturerEffective dateTypeVersion
Cyclobenzaprine hydrochloride Tablets, USPAsclemed USA, Inc. | ASCLEMED USA INC. DBA ENOVACHEM2025-08-01HUMAN PRESCRIPTION DRUG LABEL2